The Effect of Noninvasive Bariatric Surgery on the Levels of Certain Adipokines and Atherosclerosis Risk Factors in Patients with Metabolic Syndrome.

Besides glucose intolerance, dyslipidemia, and hypertension, visceral obesity is one of the most important atherogenic pathological factors in patients with metabolic syndrome (MetS). The aim of this study is to examine whether weight loss following BioEnterics Intragastric Balloon (BIB-system) therapy affects adipokine concentration and atherosclerosis risk factor profile in patients with MetS. The study group comprised 30 patients (17 female, BMI = 38.

Usefulness of New Indicators of Obesity (BAI and VAI) in Estimation of Weight Reduction.

Obesity is responsible for a large proportion of the total burden of diseases in Europe. The aim of this study was to compare classic anthropometric parameters with new obesity-related indices (the visceral adiposity index [VAI] and the body adiposity index [BAI]) and to examine their usefulness in the assessment of weight reduction and its effect on the leptin concentration. We tested 50 patients with obesity, undergoing the implementation of the BioEnterics Intragastric Balloon (BIB-system) for 6 months.

[Chosen anthropometric parameters and concentrations of leptin and adiponectin in extreme obese patients treated with implantation of a gastric balloon].

Unlabelled: Fatty tissue derived adipocytokines regulate appetite, but in abnormal concentration impair systemic metabolic homeostasis and make the patients prone to inflammatory related disorders. The aim of study was to examine whether weight loss in patients after implementation of a gastric balloon is reflected in changes in chosen anthropometrical parameters and in the concentration of leptin and adiponectin in serum.

Materials And Methods: The study group consisted of 18 extreme obese patients (BMI>39.